Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Ticks bite in foresters]M Livio, A Mobilia, S Abbate, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 19, 1998
Age-related effects of acidosis in isolated cardiac muscleP Abete, P Ferrara, S Bianco, et al.
Journal of the American Geriatrics Society|November 11, 1998
Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study GroupF Cacciatore, P Abete, N Ferrara, et al.
International Journal of Colorectal Disease|June 9, 2004
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 1, 1996
The role of aging on the control of contractile force by Na(+)-Ca2+ exchange in rat papillary muscleP Abete, N Ferrara, A Cioppa, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 19, 2013
Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugsM Coscia, L Gentilini, S Laureti, et al.
Digestive Diseases and Sciences|April 5, 2000
Severe and relapsing upper gastrointestinal bleeding in a patient with Glanzmann's thrombastheniaC Calabrese, G Di Febo, A Areni, et al.
Journal of Medicinal Chemistry|February 1, 1989
New brain perfusion imaging agents based on 99mTc-bis(aminoethanethiol) complexes: stereoisomers and biodistributionH F Kung, Y Z Guo, C C Yu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 16, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)K L Winthrop, X Mariette, J T Silva, et al.
Pageof 27